167 results
Page 2 of 9
8-K
EX-10.2
pv7xvxi
22 Dec 22
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-10.3
3315dyuzybi
22 Dec 22
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-10.1
lotjrkoq
22 Dec 22
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-10.1
xtjzkj
22 Nov 22
Qualigen Therapeutics, Inc. Announces 1-for-10 Reverse Stock Split
9:10am
8-K
EX-10.2
90ea nkr23ck
22 Nov 22
Qualigen Therapeutics, Inc. Announces 1-for-10 Reverse Stock Split
9:10am
8-K
EX-10.1
lezk4
2 Jun 22
Qualigen Therapeutics Acquires Majority Stake in Infectious
9:10am
8-K
EX-10.2
t5pt dh60xn8r
2 Jun 22
Qualigen Therapeutics Acquires Majority Stake in Infectious
9:10am
8-K
EX-10.3
t4mezagfsy
1 Dec 21
Qualigen Therapeutics, Inc. Announces Closing of $8.82 Million Registered Direct Offering
3:39pm
8-K
EX-10.2
gt86mutdd4qxrby
1 Dec 21
Qualigen Therapeutics, Inc. Announces Closing of $8.82 Million Registered Direct Offering
3:39pm
8-K
EX-10.1
utjhf2u5 7ye0
1 Dec 21
Qualigen Therapeutics, Inc. Announces Closing of $8.82 Million Registered Direct Offering
3:39pm